Publications from OUS - Experimental Immunotherapy (Olweus)

31 publications found

Publications 2020

  1. Evers M, Ten Broeke T, Jansen JHM, Nederend M, Hamdan F, Reiding KR, Meyer S, Moerer P, Brinkman I, Rösner T, Lebbink RJ, Valerius T, Leusen JHW (2020)
    Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
    MAbs, 12 (1), 1795505
    DOI 10.1080/19420862.2020.1795505, PubMed 32744145

Publications 2019

  1. Ali M, Foldvari Z, Giannakopoulou E, Böschen ML, Strønen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J (2019)
    Induction of neoantigen-reactive T cells from healthy donors
    Nat Protoc, 14 (6), 1926-1943
    DOI 10.1038/s41596-019-0170-6, PubMed 31101906
  2. Olweus J, Lund-Johansen F (2019)
    Finding Neo (antigens, that is)
    Blood, 134 (2), 108-109
    DOI 10.1182/blood.2019001334, PubMed 31296544
  3. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
    Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
    NPJ Breast Cancer, 5, 13
    DOI 10.1038/s41523-019-0108-8, PubMed 30993194

Publications 2018

  1. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
    Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
    Cancer Immunol Res, 6 (4), 467-480
    DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477

Publications 2017

  1. Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M (2017)
    Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
    Sci Rep, 7 (1), 4916
    DOI 10.1038/s41598-017-04982-1, PubMed 28687807
  2. Karpanen T, Olweus J (2017)
    The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
    Front Immunol, 8, 1718
    DOI 10.3389/fimmu.2017.01718, PubMed 29321773
  3. Karpanen T, Padberg Y, van de Pavert SA, Dierkes C, Morooka N, Peterson-Maduro J, van de Hoek G, Adrian M, Mochizuki N, Sekiguchi K, Kiefer F, Schulte D, Schulte-Merker S (2017)
    An Evolutionarily Conserved Role for Polydom/Svep1 During Lymphatic Vessel Formation
    Circ Res, 120 (8), 1263-1275
    DOI 10.1161/CIRCRESAHA.116.308813, PubMed 28179432
  4. Olweus J (2017)
    Manufacture of CAR-T cells in the body
    Nat Biotechnol, 35 (6), 520-521
    DOI 10.1038/nbt.3898, PubMed 28591119
  5. Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017)
    Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
    Arthritis Res Ther, 19 (1), 284
    DOI 10.1186/s13075-017-1494-7, PubMed 29268795
  6. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
    Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
    Sci Rep, 7, 39710
    DOI 10.1038/srep39710, PubMed 28054583
  7. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
    Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
    J Autoimmun, 81, 110-119
    DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239

Publications 2016

  1. Henriksen EK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E (2016)
    Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
    J Hepatol, 66 (1), 116-122
    DOI 10.1016/j.jhep.2016.09.002, PubMed 27647428
  2. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
    Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
    Oncoimmunology, 5 (5), e1138199
    DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
  3. Strønen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, Donia M, Böschen ML, Lund-Johansen F, Olweus J, Schumacher TN (2016)
    Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
    Science, 352 (6291), 1337-41
    DOI 10.1126/science.aaf2288, PubMed 27198675
  4. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
    Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
    Clin Immunol, 175, 69-74
    DOI 10.1016/j.clim.2016.11.014, PubMed 27919819

Publications 2015

  1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
    Gene Ther, 22 (5), 391-403
    DOI 10.1038/gt.2015.4, PubMed 25652098
  2. Karpanen T, Olweus J (2015)
    T-cell receptor gene therapy--ready to go viral?
    Mol Oncol, 9 (10), 2019-42
    DOI 10.1016/j.molonc.2015.10.006, PubMed 26548533
  3. Kolstad A, Kumari S, Walczak M, Madsbu U, Hagtvedt T, Bogsrud TV, Kvalheim G, Holte H, Aurlien E, Delabie J, Tierens A, Olweus J (2015)
    Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
    Blood, 125 (1), 82-89
  4. Kolstad A, Olweus J (2015)
    "In situ" vaccination for systemic effects in follicular lymphoma
    Oncoimmunology, 4 (7), e1014773
    DOI 10.1080/2162402X.2015.1014773, PubMed 26140239
  5. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
    Hepatology, 63 (5), 1608-19
    DOI 10.1002/hep.28116, PubMed 26257205
  6. Olweus J (2015)
    Cancer immunotherapy--Converting immune failure to clinical response
    Mol Oncol, 9 (10), 1891-3
    DOI 10.1016/j.molonc.2015.10.017, PubMed 26563645
  7. Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
    Unpredicted phenotypes of two mutants of the TcR DMF5
    J Immunol Methods, 425, 37-44
    DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
  8. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J (2015)
    Soluble T-cell receptors produced in human cells for targeted delivery
    PLoS One, 10 (4), e0119559
    DOI 10.1371/journal.pone.0119559, PubMed 25875651

Publications 2014

  1. Haugaa H, Taraldsrud E, Nyrerød HC, Tønnessen TI, Foss A, Solheim BG (2014)
    Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma
    Clin Med Res, 12 (1-2), 27-32
    DOI 10.3121/cmr.2013.1168, PubMed 24415744
  2. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110

Publications 2013

  1. Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J (2013)
    Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
    Proc Natl Acad Sci U S A, 111 (1), 403-8
    DOI 10.1073/pnas.1306549111, PubMed 24344295

Publications 2012

  1. Olweus J, Kolstad A (2012)
    [Can the immune system target cancer?]
    Tidsskr Nor Laegeforen, 132 (7), 784-5
    DOI 10.4045/tidsskr.12.0156, PubMed 22511078

Publications 2011

  1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2011)
    T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
    Int J Cancer, 130 (8), 1821-32
    DOI 10.1002/ijc.26209, PubMed 21630262
  2. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
    A practical approach to T-cell receptor cloning and expression
    PLoS One, 6 (11), e27930
    DOI 10.1371/journal.pone.0027930, PubMed 22132171

Publications 2010

  1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    DOI 10.1038/leu.2010.186, PubMed 20844564

 
Page visits: 7453